TLDR Females are more likely than males to experience long-COVID symptoms and heart issues.
The PoLoCOV-CVD study examined 886 healthy individuals (443 males and 443 females) one year after COVID-19 recovery to assess the impact of sex on long-COVID symptoms and cardiovascular complications. The findings revealed that females reported a higher frequency of long-COVID symptoms, including hair loss (5.4% vs. 0.7%), memory and concentration disturbances, and headaches, compared to males. Females also exhibited lower mean arterial pressure and pulse pressure, higher heart rates, and more arrhythmias, while males showed more ECG abnormalities. The study underscores significant sex differences in long-COVID impacts, indicating that females are at a higher risk for persistent symptoms.
202 citations
,
January 2022 in “Journal of Clinical Medicine” Women are more likely to have long-term post-COVID symptoms than men.
25 citations
,
December 2021 in “Journal of Medical Virology” COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.
44 citations
,
January 2021 in “Dermatologic Therapy” COVID-19 may cause hair loss due to infection stress or treatments.
51 citations
,
November 2020 in “Journal of the European Academy of Dermatology and Venereology” COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.
31 citations
,
May 2020 in “Dermatologic Therapy” Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.
Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.
213 citations
,
June 2017 in “Rheumatology” The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.
1 citations
,
December 2023 in “Life” PRP helps skin heal, possibly through special cells called telocytes.
April 2024 in “International journal of molecular sciences” Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.
November 2024 in “Frontiers in Medicine” Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.
